Literature DB >> 23296781

BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.

Stefano Espinoza1, Bernard Masri, Ali Salahpour, Raul R Gainetdinov.   

Abstract

It is evident that G protein-coupled receptors (GPCRs) such as D2 dopamine receptor and functionally related Trace Amine Associated Receptor 1 (TAAR1) can engage both in G protein-dependent (e.g., cAMP-mediated) and -independent β-arrestin-mediated signaling modalities. Both of these signaling events can be monitored in real-time and in live cells by using new biosensors based on a Bioluminescence Resonance Energy Transfer (BRET) approach. Here we discuss the practical applications of BRET to analyze dynamics of cAMP modulation via an EPAC biosensor as well as recruitment of β-arrestin2 to the D2 dopamine receptor. Combination of these approaches allows for a comparison of activity of pharmacological compounds on these signaling modalities as demonstrated for various antipsychotics as regard to D2 dopamine receptor. Furthermore, analysis of cAMP concentrations in cells expressing TAAR1 provides a simple high-throughput screening method to identify new ligands for this receptor. These BRET approaches could be applied for the characterization of pharmacology and signaling of variety of other GPCRs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296781     DOI: 10.1007/978-1-62703-251-3_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 2.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

3.  Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397.

Authors:  Stefano Espinoza; Damiana Leo; Tatyana D Sotnikova; Mohammed Shahid; Tiina M Kääriäinen; Raul R Gainetdinov
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

4.  Discovery and In Vivo Efficacy of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 4-(2-Aminoethyl)-N-(3,5-dimethylphenyl)piperidine-1-carboxamide Hydrochloride (AP163) for the Treatment of Psychotic Disorders.

Authors:  Mikhail Krasavin; Anatoly A Peshkov; Alexey Lukin; Kristina Komarova; Lyubov Vinogradova; Daria Smirnova; Evgeny V Kanov; Savelii R Kuvarzin; Ramilya Z Murtazina; Evgeniya V Efimova; Maxim Gureev; Kirill Onokhin; Konstantin Zakharov; Raul R Gainetdinov
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

5.  Discovery of Novel Trace Amine-Associated Receptor 5 (TAAR5) Antagonists Using a Deep Convolutional Neural Network.

Authors:  Carlotta Bon; Ting-Rong Chern; Elena Cichero; Terrence E O'Brien; Stefano Gustincich; Raul R Gainetdinov; Stefano Espinoza
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.